The incidence of coronary heart disease and the population attributable fraction of its risk factors in Tehran: A 10-year population-based cohort study

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Khalili, Davood ^a,b   Sheikholeslami, Farhad Haj ^a   Bakhtiyari, Mahmood ^a,c   Azizi, Fereidoun ^d   Momenan, Amir Abbas ^a   Hadaegh, Farzad ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE DISTRIBUTION; AGED; AGING; ARTICLE; COHORT ANALYSIS; DIABETES MELLITUS; FEMALE; HUMAN; HYPERTENSION; INCIDENCE; IRAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SMOKING; BLOOD; CORONARY DISEASE; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY;

ADULT; AGED; AGING; CHOLESTEROL, HDL; COHORT STUDIES; CORONARY DISEASE; DIABETES MELLITUS; FEMALE; HUMANS; HYPERTENSION; INCIDENCE; IRAN; MALE; MIDDLE AGED; RISK FACTORS; SEX FACTORS; SMOKING;

EID: 84924867228     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0105804     Document Type: Article

References (37)

1. Guilbert JJ (2003) The world health report 2002-reducing risks, promoting healthy life. Abington: Carfax Publishing Limited. 230 p.
2. Khalili D, Mosavi-Jarrahi A, Eskandari F, Mousavi-Jarrahi Y, Hadaegh F, et al. (2012) Evaluation of cause of deaths' validity using outcome measures from a prospective, population based cohort study in Tehran, Iran. PLoS One 7: e31427.
3. Hadaegh F, Harati H, Ghanbarian A, Azizi F (2009) Prevalence of coronary heart disease among Tehran adults: Tehran Lipid and Glucose Study. East Mediterr Health J 15: 157-166.
4. Azizi F, Rahmani M, Emami H, Mirmiran P, Hajipour R, et al. (2002) Cardiovascular risk factors in an Iranian urban population: Tehran lipid and glucose study (phase 1). Soz Praventivmed 47: 408-426. (Pubitemid 36285040)
5. National Heart Lung and Blood Institute (2002) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106: 3143-3421.
6. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, et al. (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364: 937-952. (Pubitemid 39208455)
7. Motlagh B, O'Donnell M, Yusuf S (2009) Prevalence of cardiovascular risk factors in the Middle East: a systematic review. Eur J Cardiovasc Prev Rehabil 16: 268-280.
8. Khalili D, Hadaegh F, Soori H, Steyerberg EW, Bozorgmanesh M, et al. (2012) Clinical Usefulness of the Framingham Cardiovascular Risk Profile Beyond Its Statistical Performance: The Tehran Lipid and Glucose Study. Am J Epidemiol 176: 177-186.
9. Azizi F, Ghanbarian A, Momenan AA, Hadaegh F, Mirmiran P, et al. (2009) Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials 10: 5.
10. Hadaegh F, Harati H, Ghanbarian A, Azizi F (2006) Association of total cholesterol versus other serum lipid parameters with the short-term prediction of cardiovascular outcomes: Tehran Lipid and Glucose Study. Eur J Cardiovasc Prev Rehabil 13: 571-577. (Pubitemid 44162159)
11. Statistical Center of Iran (2006) Population by age, sex, and residence status, 1385 census. Available: http://amar.sci.org.ir/index-e.aspx. Accessed 2014 Apr 15.
12. Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJL, Lozano R, et al. (2001) Age standardization of rates: a new WHO standard. Available: http://www.who.int/healthinfo/paper31.pdf. Accessed 2014 Apr 15.
13. Kleinbaum DG, Klein M (2005) Survival Analysis. A Self-Learning Text. New York: Springer. 257 p.
14. Eide GE, Gefeller O (1995) Sequential and average attributable fractions as aids in the selection of preventive strategies. J Clin Epidemiol 48: 645-655.
15. Rückinger S, Von Kries R, Toschke AM (2009) An illustration of and programs estimating attributable fractions in large scale surveys considering multiple risk factors. BMC Med Res Methodol 9: 7.
16. Hosmer DW, Hosmer T, Le Cessie S, Lemeshow S (1997) A comparison of goodness-of-fit tests for the logistic regression model. Stat Med 16: 965-980. (Pubitemid 27198985)
17. Centers for Disease Control (1992) Coronary heart disease incidence, by sex-United States, 1971-1987. MMWR Morb Mortal Wkly Rep 41: 526-529.
18. Menotti A, Lanti M, Puddu P, Kromhout D (2000) Coronary heart disease incidence in northern and southern European populations: a reanalysis of the seven countries study for a European coronary risk chart. Heart 84: 238-244.
19. Sun J, Liu J, Xie X, Wei Z, Wang W, et al. (2012) Surveillance on the incidence of acute coronary events in the permanent residents of Beijing aged 25 years and more from 2007 to 2009. Zhonghua xin xue guan bing za zhi 40: 194.
20. Kitamura A, Sato S, Kiyama M, Imano H, Iso H, et al. (2008) Trends in the incidence of coronary heart disease and stroke and their risk factors in Japan, 1964 to 2003: the Akita-Osaka study. J Am Coll Cardiol 52: 71-79. (Pubitemid 351852929)
21. Onat A, Can G, Hergenc G, Hergenç G, Küçükdurmaz Z, et al. (2010) High absolute coronary disease risk among Turks: involvement of risk factors additional to conventional ones. Cardiology 115: 297-306.
22. Talaei M, Sarrafzadegan N, Sadeghi M, Oveisgharan S, Marshall T, et al. (2013) Incidence of cardiovascular diseases in an Iranian population: the Isfahan Cohort Study. Arch Iran Med 16: 138-144.
23. Kiani S, Bayanzadeh M, Tavallaee M, Hogg RS (2010) The Iranian population is graying: are we ready? Arch Iran Med 13: 333-339.
24. Booth GL, Kapral MK, Fung K, Tu JV (2006) Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study. Lancet 368: 29-36. (Pubitemid 43947203)
25. Hozawa A, Folsom AR, Sharrett AR, Chambless LE (2007) Absolute and attributable risks of cardiovascular disease incidence in relation to optimal and borderline risk factors: comparison of African American with white subjects-Atherosclerosis Risk in Communities Study. Arch Intern Med 167: 573-579. (Pubitemid 46513226)
26. Lakatta EG (2002) Age-associated cardiovascular changes in health: impact on cardiovascular disease in older persons. Heart Fail Rev 7: 29-49.
27. Odden MC, Coxson PG, Moran A, Lightwood JM, Goldman L, et al. (2011) The impact of the aging population on coronary heart disease in the United States. Am J Med 124: 827-833. e825.
28. Sniderman AD, Furberg CD (2008) Age as a modifiable risk factor for cardiovascular disease. Lancet 371: 1547-1549.
29. Onat A, Can G, Hergenc G, Ugur M, Yuksel H (2012) Coronary disease risk prediction algorithm warranting incorporation of C-reactive protein in Turkish adults, manifesting sex difference. Nutr Metab Cardiovasc Dis 22: 643-650.
30. Whiting DR, Guariguata L, Weil C, Shaw J (2011) IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 94: 311-321.
31. Forssas EH, Keskimäki IT, Reunanen AR, Koskinen SV (2008) Coronary heart disease among diabetic and nondiabetic people-socioeconomic differences in incidence, prognosis and mortality. J Diabetes Complications 22: 10.
32. Hadaegh F, Khalili D, Fahimfar N, Tohidi M, Eskandari F, et al. (2009) Glucose intolerance and risk of cardiovascular disease in Iranian men and women: results of the 7.6-year follow-up of the Tehran Lipid and Glucose Study (TLGS). J Endocrinol Invest 32: 724.
33. Huxley R, Barzi F, Woodward M (2006) Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. Bmj 332: 73-78.
34. Esteghamati A, Abbasi M, Alikhani S, Gouya MM, Delavari A, et al. (2008) Prevalence, awareness, treatment, and risk factors associated with hypertension in the Iranian population: the national survey of risk factors for noncommunicable diseases of Iran. Am J Hypertens 21: 620-626. (Pubitemid 351733363)
35. Moran A, DeGennaro V, Ferrante D, Coxson PG, Palmas W, et al. (2011) Coronary heart disease and stroke attributable to major risk factors is similar in Argentina and the United States: The Coronary Heart Disease Policy Model. Int J Cardiol 150: 332-337.
36. Lu Y, Hajifathalian K, Ezzati M, Woodward M, Rimm EB, et al. (2014) Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1.8 million participants. Lancet 383: 970-983.
37. Azizi F, Khalili D, Aghajani H, Esteghamati A, Hosseinpanah F, et al. (2010) Appropriate waist circumference cut-off points among Iranian adults: the first report of the Iranian National Committee of Obesity. Arch Iran Med 13: 243-244.